Catalyst

Slingshot members are tracking this event:

Phase 2 data of MM-121 for Heregulin Positive Non-Small Cell Lung Cancer due 2H 2018

Source Link:
http://investors.merrimack.com/news-releases/news-release-details/merrimack-strengthens-sherloc-study-mm-121-non-small-cell-lung

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MACK
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on March 12 2018: Initially expected in 2018, timeline got narrowed down to 2H 2018
http://investors.mer...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 06, 2018
Occurred Source:
http://investors.merrimack.com/news-releases/news-release-details/merrimack-completes-enrollment-randomized-phase-2-sherloc-study
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Mm-121, Heregulin Positive Non-small Cell Lung Cancer
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.